These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 9330371

  • 1. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
    Araujo DM, Hilt DC.
    Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
    [Abstract] [Full Text] [Related]

  • 2. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM, Hilt DC.
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [Abstract] [Full Text] [Related]

  • 3. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA, Miller PJ, Collins F, Jiao S.
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [Abstract] [Full Text] [Related]

  • 4. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
    Alberch J, Pérez-Navarro E, Canals JM.
    Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
    Kobayashi S, Ogren SO, Hoffer BJ, Olson L.
    Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
    [Abstract] [Full Text] [Related]

  • 14. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
    Brickell KL, Nicholson LF, Waldvogel HJ, Faull RL.
    J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C.
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [Abstract] [Full Text] [Related]

  • 16. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI.
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection.
    Lapchak PA, Araujo DM, Hilt DC, Jiao S, Collin F, Miyoshi Y, Yi A, Zhang Z, Gash DM.
    Brain Res; 1998 Apr 06; 789(1):9-22. PubMed ID: 9602028
    [Abstract] [Full Text] [Related]

  • 20. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats.
    Martin D, Miller G, Cullen T, Fischer N, Dix D, Russell D.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):247-56. PubMed ID: 8997607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.